{"recordsFiltered":49235,"recordsTotal":49235,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=35400","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=34800","results":[{"registry_id":"NCT07363421","publication_url":"https://clinicaltrials.gov/study/NCT07363421","title":"Feasibility Study Protocol: TMS-Induced LH Response in Healthy Women in the Luteal Phase","has_exemption":false,"start_date":"2026-02-24","completion_date":"2026-05-01","has_results":false,"results_due":false,"sponsor_name":"The City College of New York","sponsor_slug":"the-city-college-of-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02235857","publication_url":"https://clinicaltrials.gov/study/NCT02235857","title":"Treatment of Drug-resistant Pediatric Primary Focal Segmental Glomerulosclerosis Using the Liposorber® LA-15 System","has_exemption":false,"start_date":"2015-05-03","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Kaneka Medical America LLC","sponsor_slug":"kaneka-medical-america-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT07434271","publication_url":"https://clinicaltrials.gov/study/NCT07434271","title":"Explorative Double-Blind Placebo Controlled Crossover Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)","has_exemption":false,"start_date":"2025-12-01","completion_date":"2026-05-03","has_results":false,"results_due":false,"sponsor_name":"Kadence Bio","sponsor_slug":"kadence-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05104723","publication_url":"https://clinicaltrials.gov/study/NCT05104723","title":"A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications","has_exemption":false,"start_date":"2022-08-12","completion_date":"2026-05-04","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05687058","publication_url":"https://clinicaltrials.gov/study/NCT05687058","title":"Empagliflozin in ESKD - A Feasibility Study","has_exemption":false,"start_date":"2023-11-01","completion_date":"2026-05-04","has_results":false,"results_due":false,"sponsor_name":"University of Mississippi Medical Center","sponsor_slug":"university-of-mississippi-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05808764","publication_url":"https://clinicaltrials.gov/study/NCT05808764","title":"A Phase II, Open-label Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy","has_exemption":false,"start_date":"2024-04-26","completion_date":"2026-05-04","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07118852","publication_url":"https://clinicaltrials.gov/study/NCT07118852","title":"Developing Remote Human Milk Collection as a Novel Technique for Transcriptome Sequencing","has_exemption":false,"start_date":"2025-11-14","completion_date":"2026-05-04","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03808610","publication_url":"https://clinicaltrials.gov/study/NCT03808610","title":"Phase I/II Study of the Combination of Low-Intensity Chemotherapy and Venetoclax (ABT-199) in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)","has_exemption":false,"start_date":"2019-04-03","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04248439","publication_url":"https://clinicaltrials.gov/study/NCT04248439","title":"A Phase 2 Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype A","has_exemption":false,"start_date":"2020-07-15","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Rocket Pharmaceuticals Inc.","sponsor_slug":"rocket-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04660214","publication_url":"https://clinicaltrials.gov/study/NCT04660214","title":"Minimally Invasive Endoscopic Treatment of Zenker's Diverticulum Comparing LigaSureTM vs SB-Knife.","has_exemption":false,"start_date":"2021-06-28","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Hospital del Río Hortega","sponsor_slug":"hospital-del-rio-hortega","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327127","publication_url":"https://clinicaltrials.gov/study/NCT05327127","title":"Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Participants With Noncirrhotic Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis","has_exemption":false,"start_date":"2022-11-14","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Kowa Research Institute, Inc.","sponsor_slug":"kowa-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05453396","publication_url":"https://clinicaltrials.gov/study/NCT05453396","title":"A Pilot Study of Loncastuximab Tesirine in Specific Populations of Relapsed/Refractory B-Cell Malignancies","has_exemption":false,"start_date":"2023-08-07","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06169735","publication_url":"https://clinicaltrials.gov/study/NCT06169735","title":"Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation","has_exemption":false,"start_date":"2024-04-11","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06545916","publication_url":"https://clinicaltrials.gov/study/NCT06545916","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2 Study to Evaluate Impact of Sunobinop (V117957) on Alcohol Consumption in Subjects Diagnosed With Moderate to Severe Alcohol Use Disorder and Seeking Treatment","has_exemption":false,"start_date":"2024-10-14","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Knoa Pharma LLC","sponsor_slug":"knoa-pharma-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07031206","publication_url":"https://clinicaltrials.gov/study/NCT07031206","title":"Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07027267","publication_url":"https://clinicaltrials.gov/study/NCT07027267","title":"A Prospective, Multi-Center, Open-Label Study to Evaluate the Safety and Effectiveness of TurbAlign™ to Achieve Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery (FESS) (GAIA)","has_exemption":false,"start_date":"2025-08-04","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Spirair, Inc","sponsor_slug":"spirair-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07293611","publication_url":"https://clinicaltrials.gov/study/NCT07293611","title":"Prospective, Multicenter, Single-arm, Open-label Study to Assess the Safety and Feasibility of the Levita Magnetic Surgical System for Reduced Port in Upper Gastrointestinal Laparoscopic Procedures","has_exemption":false,"start_date":"2026-03-30","completion_date":"2026-05-05","has_results":false,"results_due":false,"sponsor_name":"Levita Magnetics","sponsor_slug":"levita-magnetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04034030","publication_url":"https://clinicaltrials.gov/study/NCT04034030","title":"Repeated Oscillatory Transcranial Magnetic Stimulation Therapy of the Epileptogenic Cortical Area in Children With Focal Continuous-Spike and Wave During Sleep","has_exemption":false,"start_date":"2019-08-01","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Children's Mercy Hospital Kansas City","sponsor_slug":"childrens-mercy-hospital-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04764942","publication_url":"https://clinicaltrials.gov/study/NCT04764942","title":"Phase 1/2 Trial of Selinexor in Combination With Pomalidomide and Dexamethasone ± Carfilzomib for Patients With Proteasome-Inhibitor and Immunomodulatory Drug Refractory Multiple Myeloma (SCOPE)","has_exemption":false,"start_date":"2021-05-06","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06060665","publication_url":"https://clinicaltrials.gov/study/NCT06060665","title":"IDEAL: A 52-week, Double-blind, Placebo-controlled, Randomized, Phase 3 Study Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)","has_exemption":false,"start_date":"2023-09-05","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593600","publication_url":"https://clinicaltrials.gov/study/NCT06593600","title":"A Phase 2 Double-Blind Placebo-Controlled Single-Dose Study of Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of REGN7544, an NPR1 Antagonist Monoclonal Antibody, in Patients With Postural Orthostatic Tachycardia Syndrome","has_exemption":false,"start_date":"2024-11-13","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06538285","publication_url":"https://clinicaltrials.gov/study/NCT06538285","title":"Pilot Clinical Trial of Ketamine-assisted Psychotherapy for Methamphetamine Use Disorder and HIV Risk Reduction","has_exemption":false,"start_date":"2025-03-04","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Nicky Mehtani, MD, MPH","sponsor_slug":"nicky-mehtani-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06840470","publication_url":"https://clinicaltrials.gov/study/NCT06840470","title":"Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia","has_exemption":false,"start_date":"2025-03-11","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07039981","publication_url":"https://clinicaltrials.gov/study/NCT07039981","title":"Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes","has_exemption":false,"start_date":"2025-07-01","completion_date":"2026-05-06","has_results":false,"results_due":false,"sponsor_name":"Insulet Corporation","sponsor_slug":"insulet-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06077864","publication_url":"https://clinicaltrials.gov/study/NCT06077864","title":"A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06230757","publication_url":"https://clinicaltrials.gov/study/NCT06230757","title":"Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial","has_exemption":false,"start_date":"2024-07-08","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06531512","publication_url":"https://clinicaltrials.gov/study/NCT06531512","title":"A Phase II/III Seamless Design, Randomized, Double-blind, Paralleled-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers","has_exemption":false,"start_date":"2024-08-16","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"Oneness Biotech Co., Ltd.","sponsor_slug":"oneness-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220161","publication_url":"https://clinicaltrials.gov/study/NCT07220161","title":"Innovative Repurposing of Trigeminal Nerve Stimulation of the Treatment of Epilepsy in Veterans","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06637514","publication_url":"https://clinicaltrials.gov/study/NCT06637514","title":"A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria","has_exemption":false,"start_date":"2025-07-16","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07473661","publication_url":"https://clinicaltrials.gov/study/NCT07473661","title":"Human Repeat Insult Patch Test (HRIPT): Assessment of Skin Irritation and Sensitization of a Collagen-Based Material in Healthy Volunteers","has_exemption":false,"start_date":"2026-02-27","completion_date":"2026-05-08","has_results":false,"results_due":false,"sponsor_name":"SerenaGroup, Inc.","sponsor_slug":"serenagroup-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05409976","publication_url":"https://clinicaltrials.gov/study/NCT05409976","title":"Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction","has_exemption":false,"start_date":"2022-10-25","completion_date":"2026-05-09","has_results":true,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07244913","publication_url":"https://clinicaltrials.gov/study/NCT07244913","title":"Therapeutic Effects of Instrument-assisted Versus Sound-assisted Soft Tissue Mobilization Among Patients With Chronic Non-specific Low Back Pain","has_exemption":false,"start_date":"2025-12-23","completion_date":"2026-05-09","has_results":false,"results_due":false,"sponsor_name":"University of Lahore","sponsor_slug":"university-of-lahore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06358313","publication_url":"https://clinicaltrials.gov/study/NCT06358313","title":"Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke, a Randomized Controlled Single-blinded Trial","has_exemption":false,"start_date":"2024-04-10","completion_date":"2026-05-10","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07585396","publication_url":"https://clinicaltrials.gov/study/NCT07585396","title":"Efficacy of Inositol in Managing Subfertility in Letrozole-resistant Polycystic Ovary Syndrome Women","has_exemption":false,"start_date":"2025-05-10","completion_date":"2026-05-10","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03860987","publication_url":"https://clinicaltrials.gov/study/NCT03860987","title":"A Phase II Study of Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18F-DCFPyL-PET/CT in Newly Diagnosed Prostate Cancer","has_exemption":false,"start_date":"2019-04-30","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03650764","publication_url":"https://clinicaltrials.gov/study/NCT03650764","title":"A Prospective Phase I and II Trial of Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2019-05-29","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04101838","publication_url":"https://clinicaltrials.gov/study/NCT04101838","title":"B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05083481","publication_url":"https://clinicaltrials.gov/study/NCT05083481","title":"A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination With Pembrolizumab and/or Standard Therapies Including Chemotherapy and/or Immunotherapy in Participants With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2021-10-19","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05794139","publication_url":"https://clinicaltrials.gov/study/NCT05794139","title":"A Phase 2, Randomised, Double-blind, Placebo-controlled, 2-way Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 in Ambulatory Adults With Type 3 Spinal Muscular Atrophy","has_exemption":false,"start_date":"2023-09-21","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"NMD Pharma A/S","sponsor_slug":"nmd-pharma-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976243","publication_url":"https://clinicaltrials.gov/study/NCT05976243","title":"A 52-week Multi-center, Randomized, Double-blind, Placebo Controlled, Basket Study With an Open-label Extension to Investigate the Efficacy, Safety, and Tolerability of Remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in Adults Inadequately Controlled by H1-antihistamines","has_exemption":false,"start_date":"2023-12-07","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06862791","publication_url":"https://clinicaltrials.gov/study/NCT06862791","title":"A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight With Co-morbidity (ASCEND)","has_exemption":false,"start_date":"2025-02-18","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07121192","publication_url":"https://clinicaltrials.gov/study/NCT07121192","title":"A Phase 2a Randomized, Observer-Blind, Study to Evaluate the Immunogenicity and Safety of mRNA-Based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age And Older","has_exemption":false,"start_date":"2025-08-25","completion_date":"2026-05-11","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05575492","publication_url":"https://clinicaltrials.gov/study/NCT05575492","title":"A Phase 1/2a Open-Label Dose-Ranging and Observer-Blind Placebo-Controlled, Safety and Immunogenicity Study of mRNA-1647 Cytomegalovirus Vaccine in Female and Male Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age","has_exemption":false,"start_date":"2022-11-07","completion_date":"2026-05-12","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06182124","publication_url":"https://clinicaltrials.gov/study/NCT06182124","title":"A PHASE 1/2, RANDOMIZED, DOUBLE-BLIND TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS 18 YEARS OF AGE AND OLDER","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-12","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07031336","publication_url":"https://clinicaltrials.gov/study/NCT07031336","title":"Photon-counting CT Post-processing Protocols for Robust Quantifications in Chest CT Scans","has_exemption":false,"start_date":"2025-11-14","completion_date":"2026-05-12","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03950076","publication_url":"https://clinicaltrials.gov/study/NCT03950076","title":"EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)","has_exemption":false,"start_date":"2019-09-20","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Population Health Research Institute","sponsor_slug":"population-health-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04825743","publication_url":"https://clinicaltrials.gov/study/NCT04825743","title":"A Phase 3 Prospective, Blinded, Randomized, Placebo Controlled, International Multicenter Study to Assess the Safety and Efficacy of a Single SQ Injection of Zalunfiban in Subjects With ST-elevation MI in the Pre-hospital Setting","has_exemption":false,"start_date":"2021-04-24","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"CeleCor Therapeutics","sponsor_slug":"celecor-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05183828","publication_url":"https://clinicaltrials.gov/study/NCT05183828","title":"Association of HSD3B1 Genotype With Response to Preoperative Letrozole Therapy Among Postmenopausal Women With Estrogen-Receptor Positive (ER+) HER2/Neu-Negative (HER2-) Invasive Carcinomas of the Breast","has_exemption":false,"start_date":"2022-01-23","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05248646","publication_url":"https://clinicaltrials.gov/study/NCT05248646","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Subjects With Immunoglobulin A Nephropathy.","has_exemption":false,"start_date":"2022-03-15","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06702995","publication_url":"https://clinicaltrials.gov/study/NCT06702995","title":"A Phase Ib/II Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Failed Prior Novel Hormone Therapy","has_exemption":false,"start_date":"2023-04-19","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Evopoint Biosciences Inc.","sponsor_slug":"evopoint-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06194825","publication_url":"https://clinicaltrials.gov/study/NCT06194825","title":"A Phase 3, Randomized Study, With Initial 24-week, Double-Blind and Placebo-Controlled Treatment Phase, Followed by An 80-week Open-label Extension Treatment Phase to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-Term Safety in Chinese Participants With Transthyretin Amyloid Cardiomyopathy (EPIC-ATTR)","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07141121","publication_url":"https://clinicaltrials.gov/study/NCT07141121","title":"Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-05-13","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01962636","publication_url":"https://clinicaltrials.gov/study/NCT01962636","title":"Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases","has_exemption":false,"start_date":"2016-12-31","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05686551","publication_url":"https://clinicaltrials.gov/study/NCT05686551","title":"A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen in Individuals With Prodromal and Early Manifest Huntington's Disease","has_exemption":false,"start_date":"2023-02-03","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06376045","publication_url":"https://clinicaltrials.gov/study/NCT06376045","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma","has_exemption":false,"start_date":"2024-05-24","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06271616","publication_url":"https://clinicaltrials.gov/study/NCT06271616","title":"A Phase II Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)","has_exemption":false,"start_date":"2024-12-13","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07006792","publication_url":"https://clinicaltrials.gov/study/NCT07006792","title":"A Phase 4, Multicenter, Open-label, Single-arm Study to Investigate the Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate Atopic Dermatitis and High Itch Burden","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-05-14","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02270814","publication_url":"https://clinicaltrials.gov/study/NCT02270814","title":"Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)","has_exemption":false,"start_date":"2015-02-02","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05218811","publication_url":"https://clinicaltrials.gov/study/NCT05218811","title":"Cryotherapy and Robotic Assisted Non Ischemic Nephron Sparring Surgery","has_exemption":false,"start_date":"2020-05-15","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Urological Research Network, LLC","sponsor_slug":"urological-research-network-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04655963","publication_url":"https://clinicaltrials.gov/study/NCT04655963","title":"Neuromodulation and Plasticity in Cognitive Control Neurocircuitry in Chronic Stroke","has_exemption":false,"start_date":"2021-01-14","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05280548","publication_url":"https://clinicaltrials.gov/study/NCT05280548","title":"A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared With Usual Standard of Care on Left Ventricular Mass Index in Participants With Fabry Disease and Left Ventricular Hypertrophy","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285813","publication_url":"https://clinicaltrials.gov/study/NCT05285813","title":"A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure","has_exemption":false,"start_date":"2022-05-06","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05143177","publication_url":"https://clinicaltrials.gov/study/NCT05143177","title":"An Adaptive Phase 2/3 Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel, 2 Arm Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"REDNVIA Co., Ltd.","sponsor_slug":"rednvia-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05382442","publication_url":"https://clinicaltrials.gov/study/NCT05382442","title":"A Phase II Study of AK112 With or Without AK117 for Patients With Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Akeso","sponsor_slug":"akeso","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05731128","publication_url":"https://clinicaltrials.gov/study/NCT05731128","title":"A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Dupilumab Therapy in Patients With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05836571","publication_url":"https://clinicaltrials.gov/study/NCT05836571","title":"Randomized Phase 2 Study of Cabozantinib, Ipilimumab, and Nivolumab in Patients With Soft Tissue Sarcoma","has_exemption":false,"start_date":"2023-10-25","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute LAO","sponsor_slug":"national-cancer-institute-lao","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885177","publication_url":"https://clinicaltrials.gov/study/NCT06885177","title":"TECTONIC CAD Intravascular Lithotripsy (IVL) IDE Study","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810726","publication_url":"https://clinicaltrials.gov/study/NCT06810726","title":"EVALUATION OF THE SAFETY AND THE CLINICAL PERFORMANCE IN TREATMENT OF CHRONIC DIABETIC FOOT ULCER, WITH THE TROPOCELLS®, BASED AUTOLOGOUS PLATELET RICH FIBRIN (Tropocells(R) Autologous PRF Systems)","has_exemption":false,"start_date":"2025-04-15","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Estar Medical dba Medical Technologies, LTD","sponsor_slug":"estar-medical-dba-medical-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06981949","publication_url":"https://clinicaltrials.gov/study/NCT06981949","title":"The Addition of Dexmedetomidine to Ropivacaine in Bilateral Erector Spinae Plane Block in Patients Undergoing Coronary Artery Bypass Surgery - A Double-blinded Randomized Clinical Trial","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Lebanese American University","sponsor_slug":"lebanese-american-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07138560","publication_url":"https://clinicaltrials.gov/study/NCT07138560","title":"BOOST-PD - Better On-time Observations of Motor Fluctuations Using Wearable Sensor Technology: A Naturalistic Study on IPX-203 for Parkinson's Disease","has_exemption":false,"start_date":"2025-07-24","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984328","publication_url":"https://clinicaltrials.gov/study/NCT06984328","title":"Efficacy and Safety Study of Acasunlimab as Monotherapy and in Combination With Pembrolizumab in Subjects With Relapsed/Refractory, Unresectable Locally Advanced or Metastatic Cutaneous Melanoma That Progressed On or After Treatment With a Checkpoint Inhibitor (ABBIL1TY MELANOMA-07)","has_exemption":false,"start_date":"2025-07-25","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07105254","publication_url":"https://clinicaltrials.gov/study/NCT07105254","title":"An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)","has_exemption":false,"start_date":"2025-08-01","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Derm Texas, PLLC","sponsor_slug":"derm-texas-pllc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07300878","publication_url":"https://clinicaltrials.gov/study/NCT07300878","title":"Comparison Of Hemodynamic Stress Response To Laryngoscopy With Video Laryngoscopy Versus Macintosh Laryngoscopy In Patients Undergoing Elective Surgeries Under General Anesthesia","has_exemption":false,"start_date":"2025-12-22","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Pakistan Institute of Medical Sciences","sponsor_slug":"pakistan-institute-of-medical-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421544","publication_url":"https://clinicaltrials.gov/study/NCT07421544","title":"A Prospective, Phase 4, Multicenter, Open-label Pilot Study of Obagi® Saypha® MagIQ™ Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07471750","publication_url":"https://clinicaltrials.gov/study/NCT07471750","title":"Acquisition and Clinical Image Evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images","has_exemption":false,"start_date":"2026-03-30","completion_date":"2026-05-15","has_results":false,"results_due":false,"sponsor_name":"Fujifilm Medical Systems USA, Inc.","sponsor_slug":"fujifilm-medical-systems-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03718637","publication_url":"https://clinicaltrials.gov/study/NCT03718637","title":"Efficacy Evaluation of Surgical Treatment Using Bioinductive Implant for Tennis Elbow (Lateral Epicondylitis)","has_exemption":false,"start_date":"2019-04-17","completion_date":"2026-05-17","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05419479","publication_url":"https://clinicaltrials.gov/study/NCT05419479","title":"Phase Ib Open-Label, Multicenter, Study Evaluating the Safety and Efficacy of 'Switch Maintenance' Combination Immunotherapy Using AB154, AB122, and Sotigalimab in Patients With Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2022-11-30","completion_date":"2026-05-17","has_results":false,"results_due":false,"sponsor_name":"James Cleary, MD, PhD","sponsor_slug":"james-cleary-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04305054","publication_url":"https://clinicaltrials.gov/study/NCT04305054","title":"A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants With Melanoma (KEYMAKER-U02): Substudy 02B","has_exemption":false,"start_date":"2020-07-01","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04896697","publication_url":"https://clinicaltrials.gov/study/NCT04896697","title":"A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of Vilastobart (XTX101) Monotherapy and Vilastobart (XTX101) and Atezolizumab Combination Therapy in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2021-09-13","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Xilio Development, Inc.","sponsor_slug":"xilio-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05900284","publication_url":"https://clinicaltrials.gov/study/NCT05900284","title":"A Randomized Clinical Trial of the Safety and Feasibility of Metformin as a Treatment for Sepsis Induced AKI.","has_exemption":false,"start_date":"2023-11-08","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Hernando Gomez","sponsor_slug":"hernando-gomez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06017609","publication_url":"https://clinicaltrials.gov/study/NCT06017609","title":"A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of JTT-861 Administered for 12 Weeks in Subjects With Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Akros Pharma Inc.","sponsor_slug":"akros-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06012435","publication_url":"https://clinicaltrials.gov/study/NCT06012435","title":"A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY TO EVALUATE SIGVOTATUG VEDOTIN COMPARED WITH DOCETAXEL IN ADULT PARTICIPANTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (BE6A LUNG-01)","has_exemption":false,"start_date":"2024-02-21","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06299098","publication_url":"https://clinicaltrials.gov/study/NCT06299098","title":"A Randomized, Double-Blind Study of The Efficacy and Safety of Trevogrumab, With or Without Garetosmab, in Addition to Semaglutide in Patients With Obesity","has_exemption":false,"start_date":"2024-03-13","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06444113","publication_url":"https://clinicaltrials.gov/study/NCT06444113","title":"A Phase IV, Prospective, Multicenter, Open-label, Mother-milk Study to Evaluate Ofatumumab Concentration in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis Receiving Ofatumumab","has_exemption":false,"start_date":"2024-11-25","completion_date":"2026-05-18","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06497556","publication_url":"https://clinicaltrials.gov/study/NCT06497556","title":"A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients With Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-09-23","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05309616","publication_url":"https://clinicaltrials.gov/study/NCT05309616","title":"Effects of IL-17A Inhibition on Idiopathic Subglottic Stenosis","has_exemption":false,"start_date":"2025-02-20","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07128901","publication_url":"https://clinicaltrials.gov/study/NCT07128901","title":"A Comparative Analysis of Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury","has_exemption":false,"start_date":"2025-12-10","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"Georgia Institute of Technology","sponsor_slug":"georgia-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07558148","publication_url":"https://clinicaltrials.gov/study/NCT07558148","title":"Pilot Study to Investigate Brain Targets for Neuromodulation in Obsessive-compulsive Disorder","has_exemption":false,"start_date":"2026-03-04","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301385","publication_url":"https://clinicaltrials.gov/study/NCT07301385","title":"Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Feasibility and Safety Study","has_exemption":false,"start_date":"2026-03-11","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"Sharp HealthCare","sponsor_slug":"sharp-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07365735","publication_url":"https://clinicaltrials.gov/study/NCT07365735","title":"A Prospective, Randomized, Controlled Trial of the TearCare MGX™ System With and Without Warming Hold (Xtend)","has_exemption":false,"start_date":"2026-03-17","completion_date":"2026-05-19","has_results":false,"results_due":false,"sponsor_name":"Sight Sciences, Inc.","sponsor_slug":"sight-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06472388","publication_url":"https://clinicaltrials.gov/study/NCT06472388","title":"Randomized Phase II Trial of Everolimus 5 mg vs 10 mg/Daily for Patients With Advanced Neuroendocrine Tumors","has_exemption":false,"start_date":"2024-04-24","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"AC Camargo Cancer Center","sponsor_slug":"ac-camargo-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06401707","publication_url":"https://clinicaltrials.gov/study/NCT06401707","title":"PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest","has_exemption":false,"start_date":"2024-05-20","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06418308","publication_url":"https://clinicaltrials.gov/study/NCT06418308","title":"Comparison of Intrathecal Epinephrine Versus Dexmedetomidine as Adjuvants in Cesarean Section","has_exemption":false,"start_date":"2024-09-17","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06941844","publication_url":"https://clinicaltrials.gov/study/NCT06941844","title":"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Emerge","has_exemption":false,"start_date":"2025-04-14","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"Definium Therapeutics US, Inc.","sponsor_slug":"definium-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214272","publication_url":"https://clinicaltrials.gov/study/NCT07214272","title":"A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing Procedures Using the Next Generation Fraxel® FTX Laser System in Participants With Dyschromia, Cutaneous Lesions, and Periorbital Rhytids","has_exemption":false,"start_date":"2025-10-17","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07264517","publication_url":"https://clinicaltrials.gov/study/NCT07264517","title":"A Phase 2, Double-masked, Randomized, Vehicle-controlled Study Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease","has_exemption":false,"start_date":"2025-11-03","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"Instituto Grifols, S.A.","sponsor_slug":"instituto-grifols-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07216937","publication_url":"https://clinicaltrials.gov/study/NCT07216937","title":"Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing in the Normal Range","has_exemption":false,"start_date":"2025-11-07","completion_date":"2026-05-20","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04437498","publication_url":"https://clinicaltrials.gov/study/NCT04437498","title":"Non-Invasive Vagal Nerve Stimulation in Veterans With Mild Traumatic Brain Injury (mTBI)","has_exemption":false,"start_date":"2021-02-25","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574868","publication_url":"https://clinicaltrials.gov/study/NCT05574868","title":"Evaluation of the Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis for the Treatment of Patients With Erectile Dysfunction","has_exemption":false,"start_date":"2022-07-11","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"Rigicon, Inc.","sponsor_slug":"rigicon-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05378100","publication_url":"https://clinicaltrials.gov/study/NCT05378100","title":"Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)","has_exemption":false,"start_date":"2023-01-01","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047444","publication_url":"https://clinicaltrials.gov/study/NCT06047444","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Chronic Migraine in Adult Participants","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516887","publication_url":"https://clinicaltrials.gov/study/NCT06516887","title":"A Phase Ib/II Open-Label, Dose-Escalation, Safety, Pharmacokinetic, Pharmacodynamic and Efficacy Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma","has_exemption":false,"start_date":"2024-12-27","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07055516","publication_url":"https://clinicaltrials.gov/study/NCT07055516","title":"A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"NodThera Limited","sponsor_slug":"nodthera-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07273149","publication_url":"https://clinicaltrials.gov/study/NCT07273149","title":"A Decentralised, Open-labelled, Clinical Study to Assess the Effectiveness of a Marketed Denture Adhesive in Food Occlusion in Denture Wearers in a Real-world Setting","has_exemption":false,"start_date":"2025-12-05","completion_date":"2026-05-21","has_results":false,"results_due":false,"sponsor_name":"HALEON","sponsor_slug":"haleon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04298203","publication_url":"https://clinicaltrials.gov/study/NCT04298203","title":"Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity","has_exemption":false,"start_date":"2021-08-04","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05302063","publication_url":"https://clinicaltrials.gov/study/NCT05302063","title":"A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Clinical Outcomes and Pathology of Painful Diabetic Peripheral Neuropathy (pDPN)","has_exemption":false,"start_date":"2022-09-22","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05817812","publication_url":"https://clinicaltrials.gov/study/NCT05817812","title":"A Phase 3b Open-label Study Evaluating Physical Activity and Joint Health in Previously Treated Patients ≥12 Years With Severe Haemophilia A Treated With Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (Efanesoctocog Alfa) for 24 Months","has_exemption":false,"start_date":"2023-07-31","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Swedish Orphan Biovitrum","sponsor_slug":"swedish-orphan-biovitrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996471","publication_url":"https://clinicaltrials.gov/study/NCT05996471","title":"A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion With rHuPH20, in Combination With CAB LA to Standard of Care in Virologically Suppressed Adults Living With HIV","has_exemption":false,"start_date":"2023-08-17","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06744205","publication_url":"https://clinicaltrials.gov/study/NCT06744205","title":"A Phase I/II, Randomized, Modified Double-blind Study to Investigate the Safety and Immunogenicity of Different Doses of Hexavalent Influenza mRNA HA + mRNA NA Vaccine in Adult Participants 50 Years of Age and Older","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07443215","publication_url":"https://clinicaltrials.gov/study/NCT07443215","title":"Evaluation of Effect of Scatter on Visual Performance","has_exemption":false,"start_date":"2026-02-13","completion_date":"2026-05-22","has_results":false,"results_due":false,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04164199","publication_url":"https://clinicaltrials.gov/study/NCT04164199","title":"An Open-Label, Multicenter, Long-Term Extension Study of Treatment With Tislelizumab, Pamiparib, and Other Investigational Agents in Patients With Advanced Malignancies","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-05-23","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06744855","publication_url":"https://clinicaltrials.gov/study/NCT06744855","title":"Effect of Semiconductor Embedded Therapeutic Gloves on the Mitigation of Hand Osteoarthritis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-05-23","has_results":false,"results_due":false,"sponsor_name":"Altoona Center for Clinical Research","sponsor_slug":"altoona-center-for-clinical-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084116","publication_url":"https://clinicaltrials.gov/study/NCT07084116","title":"Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin: an Open-label Within-subject Randomized Study","has_exemption":false,"start_date":"2025-07-14","completion_date":"2026-05-23","has_results":false,"results_due":false,"sponsor_name":"James Thomas Pathoulas","sponsor_slug":"james-thomas-pathoulas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04910269","publication_url":"https://clinicaltrials.gov/study/NCT04910269","title":"An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19","has_exemption":false,"start_date":"2021-08-06","completion_date":"2026-05-24","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06143046","publication_url":"https://clinicaltrials.gov/study/NCT06143046","title":"A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Pregnant Women, and Safety and Immunogenicity in Infants Born to Vaccinated Mothers","has_exemption":false,"start_date":"2023-11-15","completion_date":"2026-05-25","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727578","publication_url":"https://clinicaltrials.gov/study/NCT06727578","title":"A Pilot Assessment of the Safety and Efficacy of Pleural Irrigation for Retained Pleural Infection Using a Novel Irrigation Device","has_exemption":false,"start_date":"2025-05-25","completion_date":"2026-05-25","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02094794","publication_url":"https://clinicaltrials.gov/study/NCT02094794","title":"Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) Given in Combination With Cyclophosphamide and Etoposide as Conditioning for Allogeneic (HSCT) in Patients With High-Risk Acute Lymphocytic or Myelogenous Leukemia","has_exemption":false,"start_date":"2014-05-12","completion_date":"2026-05-26","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04009499","publication_url":"https://clinicaltrials.gov/study/NCT04009499","title":"A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","has_exemption":false,"start_date":"2019-08-13","completion_date":"2026-05-26","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05376878","publication_url":"https://clinicaltrials.gov/study/NCT05376878","title":"Pilot Study to Evaluate 64Cu-DOTA-Trastuzumab Imaging in Patients With HER2+ Breast Cancer With Brain Metastatsis Treated With Fam-Trastuzumab Deruxtecan","has_exemption":false,"start_date":"2022-12-21","completion_date":"2026-05-26","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04287647","publication_url":"https://clinicaltrials.gov/study/NCT04287647","title":"Transpyloric Stenting for Refractory Gastroparesis Prior to Gastric Per-Oral Endoscopic Myotomy: A Prospective Sham Study","has_exemption":false,"start_date":"2019-05-15","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04342429","publication_url":"https://clinicaltrials.gov/study/NCT04342429","title":"RAD4649-19: Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-03-19","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05505916","publication_url":"https://clinicaltrials.gov/study/NCT05505916","title":"An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema Type I or II","has_exemption":false,"start_date":"2022-10-24","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"KalVista Pharmaceuticals, Ltd.","sponsor_slug":"kalvista-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05511922","publication_url":"https://clinicaltrials.gov/study/NCT05511922","title":"A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial","has_exemption":false,"start_date":"2022-10-24","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"KalVista Pharmaceuticals, Ltd.","sponsor_slug":"kalvista-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047457","publication_url":"https://clinicaltrials.gov/study/NCT06047457","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Episodic Migraine in Adult Participants","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06851858","publication_url":"https://clinicaltrials.gov/study/NCT06851858","title":"A Phase II Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist","has_exemption":false,"start_date":"2025-03-12","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07501052","publication_url":"https://clinicaltrials.gov/study/NCT07501052","title":"An Evaluation of the Clinical Usability of the SCD411 Prefilled Syringe as a Proposed Biosimilar to US-licensed Eylea®","has_exemption":false,"start_date":"2026-05-13","completion_date":"2026-05-27","has_results":false,"results_due":false,"sponsor_name":"Sam Chun Dang Pharm. Co. Ltd.","sponsor_slug":"sam-chun-dang-pharm-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06513312","publication_url":"https://clinicaltrials.gov/study/NCT06513312","title":"A Phase 2, Open-label, Multicenter, Randomized Study to Evaluate the Persistence, Safety, Acceptability, and Pharmacokinetics of Twice Yearly Long-acting Subcutaneous Lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP) in People Who Would Benefit From PrEP","has_exemption":false,"start_date":"2024-10-07","completion_date":"2026-05-28","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07168564","publication_url":"https://clinicaltrials.gov/study/NCT07168564","title":"Post Market Clinical Study to Compare Vision With Essilor® AVA™ Lenses Following AVA™ Refraction Protocol to Equivalent Lenses Following Gold Standard Refraction Protocol.","has_exemption":false,"start_date":"2025-09-22","completion_date":"2026-05-28","has_results":false,"results_due":false,"sponsor_name":"Essilor International","sponsor_slug":"essilor-international","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03847428","publication_url":"https://clinicaltrials.gov/study/NCT03847428","title":"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation","has_exemption":false,"start_date":"2019-04-29","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04550442","publication_url":"https://clinicaltrials.gov/study/NCT04550442","title":"A Phase I/II Study of Venetoclax in Combination With Azacitidine in Relapsed/Refractory High-Risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)","has_exemption":false,"start_date":"2020-09-04","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04463771","publication_url":"https://clinicaltrials.gov/study/NCT04463771","title":"An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)","has_exemption":false,"start_date":"2021-01-26","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05746572","publication_url":"https://clinicaltrials.gov/study/NCT05746572","title":"A Pilot Study of MDMA-Assisted Massed Exposure Therapy for PTSD (MDMA PE)","has_exemption":false,"start_date":"2024-02-13","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06273891","publication_url":"https://clinicaltrials.gov/study/NCT06273891","title":"Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes: A Cluster Randomized Comparative Effectiveness Trial","has_exemption":false,"start_date":"2024-03-08","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06532032","publication_url":"https://clinicaltrials.gov/study/NCT06532032","title":"61186372PANSC2003: 61186372PANSC2003 ISA#3 Platform Trial","has_exemption":false,"start_date":"2024-07-23","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06611436","publication_url":"https://clinicaltrials.gov/study/NCT06611436","title":"BeCoMe-9: A Phase 1/2 Dose Escalation and Expansion Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B","has_exemption":false,"start_date":"2024-12-04","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Be Biopharma","sponsor_slug":"be-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712407","publication_url":"https://clinicaltrials.gov/study/NCT06712407","title":"An Open-label Study to Assess the Efficacy and Safety of Extended TARPEYO® (Delayed-release Budesonide Capsules) Treatment in Adult Patients With Primary IgA Nephropathy Who Have Completed 9 Months of TARPEYO® 16 mg Once Daily Treatment in Real-world Clinical Practice","has_exemption":false,"start_date":"2024-12-17","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Calliditas Therapeutics AB","sponsor_slug":"calliditas-therapeutics-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533449","publication_url":"https://clinicaltrials.gov/study/NCT06533449","title":"Development of the Couplet Care Bassinet to Support Safe Implementation of Skin-to-skin Contact and rooming-in on Postnatal Units","has_exemption":false,"start_date":"2025-01-09","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05569239","publication_url":"https://clinicaltrials.gov/study/NCT05569239","title":"Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Immunogenicity and Safety of One Dose of OVX836 Influenza Vaccine 480μg, After Intramuscular Administration in Healthy Subjects Aged 18-59 Years","has_exemption":false,"start_date":"2025-09-08","completion_date":"2026-05-29","has_results":false,"results_due":false,"sponsor_name":"Osivax","sponsor_slug":"osivax","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03600883","publication_url":"https://clinicaltrials.gov/study/NCT03600883","title":"A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)","has_exemption":false,"start_date":"2018-08-27","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03996265","publication_url":"https://clinicaltrials.gov/study/NCT03996265","title":"Randomized Placebo Controlled Trial of Bupropion For Cancer Related Fatigue","has_exemption":false,"start_date":"2019-06-27","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Rochester NCORP Research Base","sponsor_slug":"university-of-rochester-ncorp-research-base","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04015778","publication_url":"https://clinicaltrials.gov/study/NCT04015778","title":"A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China","has_exemption":false,"start_date":"2019-08-08","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Guangdong Association of Clinical Trials","sponsor_slug":"guangdong-association-of-clinical-trials","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128670","publication_url":"https://clinicaltrials.gov/study/NCT04128670","title":"Effects of Kinesio Tape on Delayed Onset Muscle Soreness","has_exemption":false,"start_date":"2020-01-30","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04396821","publication_url":"https://clinicaltrials.gov/study/NCT04396821","title":"A Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of TST001 Administered as Monotherapy or in Combination With Nivolumab or Standard of Care in Patients With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2020-05-28","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Suzhou Transcenta Therapeutics Co., Ltd.","sponsor_slug":"suzhou-transcenta-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04408313","publication_url":"https://clinicaltrials.gov/study/NCT04408313","title":"A Comparative Effectiveness Trial of Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Friends Research Institute, Inc.","sponsor_slug":"friends-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04558164","publication_url":"https://clinicaltrials.gov/study/NCT04558164","title":"Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment","has_exemption":false,"start_date":"2021-01-26","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04090424","publication_url":"https://clinicaltrials.gov/study/NCT04090424","title":"A Pivotal Study to Assess the Safety and Effectiveness of NovoSorb® Biodegradable Temporizing Matrix (BTM) in the Treatment of Severe Burn Skin Injuries","has_exemption":false,"start_date":"2021-09-21","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"PolyNovo Biomaterials Pty Ltd.","sponsor_slug":"polynovo-biomaterials-pty-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05097976","publication_url":"https://clinicaltrials.gov/study/NCT05097976","title":"An Oral Methylprednisolone Taper Within a Multimodal Analgesic Regimen After Total Knee Arthroplasty: a Double-Blind Randomized Placebo-Controlled Trial","has_exemption":false,"start_date":"2022-03-01","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869500","publication_url":"https://clinicaltrials.gov/study/NCT05869500","title":"Left Bundle Area Pacing Vs. Right Ventricular Pacing in Patients With Normal Left Ventricular Function -The Boston Pace Study","has_exemption":false,"start_date":"2023-05-01","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214923","publication_url":"https://clinicaltrials.gov/study/NCT06214923","title":"Neural Mechanisms of Immersive Virtual Reality in Chronic Pain","has_exemption":false,"start_date":"2024-04-09","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455098","publication_url":"https://clinicaltrials.gov/study/NCT06455098","title":"Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation With the BWI Pulsed Field Ablation System With OMNYPULSE™ Catheter","has_exemption":false,"start_date":"2024-06-28","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06189703","publication_url":"https://clinicaltrials.gov/study/NCT06189703","title":"tRNS Treatment for ADHD Symptoms","has_exemption":false,"start_date":"2024-07-15","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Innosphere","sponsor_slug":"innosphere","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06321471","publication_url":"https://clinicaltrials.gov/study/NCT06321471","title":"AeviceMD for Pediatric Asthma Management","has_exemption":false,"start_date":"2024-11-05","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Irina Dralyuk","sponsor_slug":"irina-dralyuk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06827977","publication_url":"https://clinicaltrials.gov/study/NCT06827977","title":"A Study of Microbiome Transplantation for the Treatment of Constipation and/or Significant Bloating in Patients With Systemic Sclerosis","has_exemption":false,"start_date":"2025-03-03","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342413","publication_url":"https://clinicaltrials.gov/study/NCT07342413","title":"A Single-center Prospective Double-Blind, Split-Body, Randomized Clinical Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias","has_exemption":false,"start_date":"2026-02-01","completion_date":"2026-05-30","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01370512","publication_url":"https://clinicaltrials.gov/study/NCT01370512","title":"Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension","has_exemption":false,"start_date":"2011-11-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02141919","publication_url":"https://clinicaltrials.gov/study/NCT02141919","title":"A Phase II Trial of Stereotactic Ablative Body Radiation Therapy (SABR) for Patients With Primary Renal Cancer (RCC)","has_exemption":false,"start_date":"2013-06-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02127398","publication_url":"https://clinicaltrials.gov/study/NCT02127398","title":"Fecal Microbiota Transplantation in Refractory Clostridium Difficile Colitis","has_exemption":false,"start_date":"2016-04-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02750358","publication_url":"https://clinicaltrials.gov/study/NCT02750358","title":"Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR(+) Triple Negative Breast Cancer","has_exemption":false,"start_date":"2016-05-19","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02653755","publication_url":"https://clinicaltrials.gov/study/NCT02653755","title":"The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer","has_exemption":false,"start_date":"2016-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02755272","publication_url":"https://clinicaltrials.gov/study/NCT02755272","title":"A Randomized Phase II Clinical Trial Assessing the Efficacy and Safety of MK-3475 (Pembrolizumab) in Combination With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2016-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03206502","publication_url":"https://clinicaltrials.gov/study/NCT03206502","title":"Characterizing Sleep, Stress, and Seizures in Daily Life: An Internet-based Study With the Empatica Embrace Watch and Smartphone-based Diary-alert System","has_exemption":false,"start_date":"2016-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Empatica, Inc.","sponsor_slug":"empatica-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03121001","publication_url":"https://clinicaltrials.gov/study/NCT03121001","title":"A Phase II Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease","has_exemption":false,"start_date":"2017-03-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03192020","publication_url":"https://clinicaltrials.gov/study/NCT03192020","title":"DupuytrEn Treatment EffeCtiveness Trial (DETECT): Needle Fasciotomy, Surgery or Collagenase Injection for Dupuytren's Contracture","has_exemption":false,"start_date":"2017-09-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Tampere University","sponsor_slug":"tampere-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03201094","publication_url":"https://clinicaltrials.gov/study/NCT03201094","title":"Impact of Neuromuscular Stimulation and High Protein Nutritional Supplementation on Long-term Recovery After Aneurysmal Subarachnoid Hemorrhage.","has_exemption":false,"start_date":"2017-12-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03040778","publication_url":"https://clinicaltrials.gov/study/NCT03040778","title":"Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ): A Prospective, Randomized Controlled Trial to Evaluate a Novel Non-operative Treatment","has_exemption":false,"start_date":"2018-04-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03105102","publication_url":"https://clinicaltrials.gov/study/NCT03105102","title":"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease","has_exemption":false,"start_date":"2018-04-09","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03506334","publication_url":"https://clinicaltrials.gov/study/NCT03506334","title":"Prospective Pilot Study of Anterior Vertebral Body Tethering Using Zimmer Biomet Tether System or Dynesys System Components to Treat Pediatric Scoliosis","has_exemption":false,"start_date":"2018-04-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03510208","publication_url":"https://clinicaltrials.gov/study/NCT03510208","title":"Phase I/II, Open-Label Study Evaluating the Efficacy and Pharmacokinetics of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Neoplasms During Neurosurgical Procedures","has_exemption":false,"start_date":"2018-05-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04096170","publication_url":"https://clinicaltrials.gov/study/NCT04096170","title":"Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo","has_exemption":false,"start_date":"2018-06-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03632044","publication_url":"https://clinicaltrials.gov/study/NCT03632044","title":"Evaluation of Trigeminal Nerve Blockade in the Pterygopalatine Fossa for Cleft Palate Repair: a Pilot Study","has_exemption":false,"start_date":"2018-11-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07255547","publication_url":"https://clinicaltrials.gov/study/NCT07255547","title":"Arthrosocpic Treatment of Knee Chondral Lesions: Clinical, MRI and Histologic Comparison Between the Use of PRP vs ADSCs in Addition to Marrow Stimulation Techniques","has_exemption":false,"start_date":"2019-05-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Università degli Studi dell'Aquila","sponsor_slug":"universita-degli-studi-dellaquila","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03933735","publication_url":"https://clinicaltrials.gov/study/NCT03933735","title":"A Multicenter, Phase 1, Open-label, Dose-escalation and Expansion Study of TNB-383B, a Bispecific Antibody Targeting BCMA in Subjects With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2019-06-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04175041","publication_url":"https://clinicaltrials.gov/study/NCT04175041","title":"A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC","has_exemption":false,"start_date":"2019-07-09","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04082533","publication_url":"https://clinicaltrials.gov/study/NCT04082533","title":"Effect of Intravenous Hydrocortisone on Range of Motion After Total Knee Arthroplasty: A Randomized Placebo-Controlled Trial With Nested Case-Control Study","has_exemption":false,"start_date":"2019-07-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04100148","publication_url":"https://clinicaltrials.gov/study/NCT04100148","title":"SyncAV Post-Market Trial","has_exemption":false,"start_date":"2019-10-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03987763","publication_url":"https://clinicaltrials.gov/study/NCT03987763","title":"A Phase 4, Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-122 Lotion in Pediatric Subjects With Moderate to Severe Plaque Psoriasis","has_exemption":false,"start_date":"2019-10-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03841097","publication_url":"https://clinicaltrials.gov/study/NCT03841097","title":"A Phase IV, Prospective, Randomized, Open-label, Comparative Analysis, Single-center Study of Pulse Wave Velocity Evaluation, Tacrolimus TTR and Co-efficient of Tacrolimus Variation of African American Kidney Recipients Receiving Standard of Care Immediate Release Tacrolimus Capsules or Extended Release Tacrolimus Tablets","has_exemption":false,"start_date":"2019-11-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Roy D. Bloom, MD","sponsor_slug":"roy-d-bloom-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04400292","publication_url":"https://clinicaltrials.gov/study/NCT04400292","title":"Does the Concept of the Sentinel Lymph Node Apply to Esophageal Cancer? A Prospective Assessment of Near-infrared Image-guided Lymphatic Mapping and Sentinel Lymph Node Identification in Esophageal Cancer","has_exemption":false,"start_date":"2020-05-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04360330","publication_url":"https://clinicaltrials.gov/study/NCT04360330","title":"Phase I Study to Evaluate the Safety and Feasibility of Preoperative Ablative Breast Radiotherapy (SABER) for Selected Early Stage Breast Cancer","has_exemption":false,"start_date":"2020-08-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04624698","publication_url":"https://clinicaltrials.gov/study/NCT04624698","title":"iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study","has_exemption":false,"start_date":"2020-09-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04576793","publication_url":"https://clinicaltrials.gov/study/NCT04576793","title":"Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease","has_exemption":false,"start_date":"2020-11-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Patrick Lao","sponsor_slug":"patrick-lao","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04506554","publication_url":"https://clinicaltrials.gov/study/NCT04506554","title":"A Phase II Trial of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer","has_exemption":false,"start_date":"2020-12-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565015","publication_url":"https://clinicaltrials.gov/study/NCT04565015","title":"An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency","has_exemption":false,"start_date":"2020-12-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"GC Biopharma Corp","sponsor_slug":"gc-biopharma-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03926520","publication_url":"https://clinicaltrials.gov/study/NCT03926520","title":"Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia","has_exemption":false,"start_date":"2021-01-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Brent Forester","sponsor_slug":"brent-forester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04727242","publication_url":"https://clinicaltrials.gov/study/NCT04727242","title":"Phase 2 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Gemcitabine Followed by Systemic Adjuvant Chemotherapy With Dacarbazine for Locally Recurrent Uterine Leiomyosarcoma (LMS)","has_exemption":false,"start_date":"2021-01-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04782947","publication_url":"https://clinicaltrials.gov/study/NCT04782947","title":"Epidural Stimulation and Resistance Training for Overground Locomotion After Spinal Cord Injury","has_exemption":false,"start_date":"2021-02-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"United States Department of Defense","sponsor_slug":"united-states-department-of-defense","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05044468","publication_url":"https://clinicaltrials.gov/study/NCT05044468","title":"A Randomized Blinded Controlled Trial of EXPAREL vs 1% Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement","has_exemption":false,"start_date":"2021-03-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04606914","publication_url":"https://clinicaltrials.gov/study/NCT04606914","title":"Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Are Folate Receptor α Positive","has_exemption":false,"start_date":"2021-05-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04748042","publication_url":"https://clinicaltrials.gov/study/NCT04748042","title":"Focal Radiation With Pulsed Systemic Therapy of Abiraterone, ADT, Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON): A Phase II, Single Arm, Single Institution Study","has_exemption":false,"start_date":"2021-05-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04496349","publication_url":"https://clinicaltrials.gov/study/NCT04496349","title":"A Phase IIa Study Evaluating the Pharmacokinetics, Safety and Efficacy of APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With Relapsed/Refractory T-Cell Prolymphocytic Leukemia (R/R T-PLL) or Non-Hodgkin's Lymphoma (NHL).","has_exemption":false,"start_date":"2021-07-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Ascentage Pharma Group Inc.","sponsor_slug":"ascentage-pharma-group-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04625127","publication_url":"https://clinicaltrials.gov/study/NCT04625127","title":"GaitBetter: Motor and Cognitive Training for Gait Rehabilitation and Falls Prevention in Stroke Survivors.","has_exemption":false,"start_date":"2021-07-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04836390","publication_url":"https://clinicaltrials.gov/study/NCT04836390","title":"A Phase II Pilot Study of Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant: A Multicenter Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) Study","has_exemption":false,"start_date":"2021-08-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Michael Pulsipher","sponsor_slug":"michael-pulsipher","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04782687","publication_url":"https://clinicaltrials.gov/study/NCT04782687","title":"A Phase II Trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in Combination With Selinexor for Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2021-09-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"US Oncology Research","sponsor_slug":"us-oncology-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05101096","publication_url":"https://clinicaltrials.gov/study/NCT05101096","title":"A Phase 1/2 Open-Label Study of Sacituzumab Govitecan in Japanese Patients With Advanced Solid Tumors (ASCENT-J02)","has_exemption":false,"start_date":"2021-10-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05144854","publication_url":"https://clinicaltrials.gov/study/NCT05144854","title":"A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab, Fluoropyrimidine-based and Platinum-based Chemotherapy (Hereinafter Referred to as \"Chemotherapy\") Versus Chemotherapy in Chemotherapy-naïve Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)","has_exemption":false,"start_date":"2021-11-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Ono Pharmaceutical Co. Ltd","sponsor_slug":"ono-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04862650","publication_url":"https://clinicaltrials.gov/study/NCT04862650","title":"A Phase II Trial of the Efficacy and Safety of the Combination of Cemiplimab and Low-Dose Paclitaxel and Carboplatin in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck","has_exemption":false,"start_date":"2021-11-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Marcelo Bonomi","sponsor_slug":"marcelo-bonomi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05123755","publication_url":"https://clinicaltrials.gov/study/NCT05123755","title":"A Randomized, Double-blind, Placebo-controlled, Phase 2a Multiple Ascending Dose Study to Examine the Safety, Tolerability and Efficacy of AV-001 Injection in Patients Hospitalized With Pneumonia Due To COVID-19 or Other Respiratory Infections.","has_exemption":false,"start_date":"2021-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vasomune Therapeutics, Inc.","sponsor_slug":"vasomune-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04891068","publication_url":"https://clinicaltrials.gov/study/NCT04891068","title":"BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer","has_exemption":false,"start_date":"2022-01-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04577859","publication_url":"https://clinicaltrials.gov/study/NCT04577859","title":"Improving Esophageal Protection During AF Ablation: a Multicenter Double-blind Randomized Clinical Trial","has_exemption":false,"start_date":"2022-03-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Advanced Cooling Therapy LLC, d/b/a Attune Medical","sponsor_slug":"advanced-cooling-therapy-llc-dba-attune-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05309551","publication_url":"https://clinicaltrials.gov/study/NCT05309551","title":"The Effects of Inspiratory Muscle Training Immediatley After Lung Transplantation: a Randomized Controlled Trial","has_exemption":false,"start_date":"2022-04-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05329649","publication_url":"https://clinicaltrials.gov/study/NCT05329649","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Severe Sickle Cell Disease","has_exemption":false,"start_date":"2022-05-02","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05356195","publication_url":"https://clinicaltrials.gov/study/NCT05356195","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of a Single Dose of CTX001 in Pediatric Subjects With Transfusion-Dependent β-Thalassemia","has_exemption":false,"start_date":"2022-05-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05345444","publication_url":"https://clinicaltrials.gov/study/NCT05345444","title":"Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)","has_exemption":false,"start_date":"2022-05-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05277168","publication_url":"https://clinicaltrials.gov/study/NCT05277168","title":"AN OPEN-LABEL, SINGLE-ARM, MULTI-CENTER PHASE I/IIA CLINICAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS","has_exemption":false,"start_date":"2022-05-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","sponsor_slug":"jiangsu-hengrui-medicine-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05292001","publication_url":"https://clinicaltrials.gov/study/NCT05292001","title":"Role of Single-dose Intravenous Iron Therapy for the Treatment of Anemia in the Setting of Orthopaedic Trauma: a Pilot Study","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05354232","publication_url":"https://clinicaltrials.gov/study/NCT05354232","title":"Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05113537","publication_url":"https://clinicaltrials.gov/study/NCT05113537","title":"Phase I/II Study of CDK4/6 Inhibition With Abemaciclib to Upregulate PSMA Expression Prior to 177Lu-PSMA-617 Treatment in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Chemotherapy","has_exemption":false,"start_date":"2022-07-08","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vadim S Koshkin","sponsor_slug":"vadim-s-koshkin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04796285","publication_url":"https://clinicaltrials.gov/study/NCT04796285","title":"A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor","has_exemption":false,"start_date":"2022-08-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05520359","publication_url":"https://clinicaltrials.gov/study/NCT05520359","title":"Transcutaneous Stimulation and Mobility Device Use for Individuals With Neurologic Conditions","has_exemption":false,"start_date":"2022-08-04","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04839705","publication_url":"https://clinicaltrials.gov/study/NCT04839705","title":"Post-Approval Study - Post-Market Surveillance Study to Evaluate the Long-Term Safety and Effectiveness of the WEB Device","has_exemption":false,"start_date":"2022-08-24","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Microvention-Terumo, Inc.","sponsor_slug":"microvention-terumo-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05425940","publication_url":"https://clinicaltrials.gov/study/NCT05425940","title":"A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-09-07","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Exelixis","sponsor_slug":"exelixis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05763602","publication_url":"https://clinicaltrials.gov/study/NCT05763602","title":"Intranasal Povidone Iodine (PVI) to Prevent Staphylococcus Aureus Surgical Site Infections After Operative Procedures to Fix High-Energy Lower Extremity Fractures (POTENT Study)","has_exemption":false,"start_date":"2022-09-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Loreen Herwaldt","sponsor_slug":"loreen-herwaldt","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05339126","publication_url":"https://clinicaltrials.gov/study/NCT05339126","title":"RNS System Feasibility Study of Thalamocortical Brain-Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome","has_exemption":false,"start_date":"2022-10-04","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"NeuroPace","sponsor_slug":"neuropace","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05546268","publication_url":"https://clinicaltrials.gov/study/NCT05546268","title":"A Phase 1/2 Study of Oral MRT-2359 in Patients With MYC-Driven and Other Selected Solid Tumors Including Lung Cancer and Diffuse B-Cell Lymphoma","has_exemption":false,"start_date":"2022-10-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Monte Rosa Therapeutics, Inc","sponsor_slug":"monte-rosa-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05426525","publication_url":"https://clinicaltrials.gov/study/NCT05426525","title":"Use of Empagliflozin to Treat Prediabetes - a Randomized, Double-blind, Placebo-controlled 13-week Intervention Trial","has_exemption":false,"start_date":"2022-10-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Oregon State University","sponsor_slug":"oregon-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05478213","publication_url":"https://clinicaltrials.gov/study/NCT05478213","title":"Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters","has_exemption":false,"start_date":"2022-10-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05354947","publication_url":"https://clinicaltrials.gov/study/NCT05354947","title":"Effects of Multi-Site Abdominal Ultrasound Stimulation on Glycemic Control in T2DM","has_exemption":false,"start_date":"2022-11-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05384847","publication_url":"https://clinicaltrials.gov/study/NCT05384847","title":"Effects of Triiodothyronine (T3) in Ischemic Heart Failure","has_exemption":false,"start_date":"2022-12-02","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531526","publication_url":"https://clinicaltrials.gov/study/NCT05531526","title":"A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 Over 52 Weeks in Participants With Early Alzheimer's Disease (Polaris-AD)","has_exemption":false,"start_date":"2022-12-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AriBio Co., Ltd.","sponsor_slug":"aribio-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05645107","publication_url":"https://clinicaltrials.gov/study/NCT05645107","title":"A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment Compared to Placebo Plus Standard Medical Treatment to Prevent Infections in Patients With Hypogammaglobulinemia and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-12-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05551936","publication_url":"https://clinicaltrials.gov/study/NCT05551936","title":"A Single Arm Phase I/II Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma Big Ten Cancer Research Consortium BTCRC-LYM20-463","has_exemption":false,"start_date":"2023-01-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Vaishalee Kenkre","sponsor_slug":"vaishalee-kenkre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05127915","publication_url":"https://clinicaltrials.gov/study/NCT05127915","title":"A Prospective, Multicenter, Pivotal Study With Randomized Controlled Prophylactic and Independent Therapeutic Cohorts to Evaluate the Safety and Efficacy of an Absorbable Vena Cava Filter for Pulmonary Embolism Prevention","has_exemption":false,"start_date":"2023-01-27","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Adient Medical","sponsor_slug":"adient-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04661995","publication_url":"https://clinicaltrials.gov/study/NCT04661995","title":"Notched Noise Therapy for Suppression of Tinnitus: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05830110","publication_url":"https://clinicaltrials.gov/study/NCT05830110","title":"Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease","has_exemption":false,"start_date":"2023-03-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Synergic Medical Technologies, Inc.","sponsor_slug":"synergic-medical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05556824","publication_url":"https://clinicaltrials.gov/study/NCT05556824","title":"A Multi-Center Study of Panosyl-Isomaltooligosaccharides (PIMO) Adjunctive to Proton Pump Inhibitor (PPI) Therapy to Treat Gastroesophageal Reflux Disease (GERD) in Subjects Who Are PPI-Responders or PPI-Partial Responders","has_exemption":false,"start_date":"2023-03-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Microbiome Health Sciences","sponsor_slug":"microbiome-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05700942","publication_url":"https://clinicaltrials.gov/study/NCT05700942","title":"Transcutaneous Spinal Direct Current Stimulation to Enhance Locomotor Rehabilitation After Spinal Cord Injury","has_exemption":false,"start_date":"2023-03-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05741333","publication_url":"https://clinicaltrials.gov/study/NCT05741333","title":"Pivotal In-Office Clinical Study of the Solo+ Tympanostomy Tube Device","has_exemption":false,"start_date":"2023-03-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"AventaMed DAC","sponsor_slug":"aventamed-dac","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05654922","publication_url":"https://clinicaltrials.gov/study/NCT05654922","title":"A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant","has_exemption":false,"start_date":"2023-04-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Renovion, Inc.","sponsor_slug":"renovion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05593588","publication_url":"https://clinicaltrials.gov/study/NCT05593588","title":"Senolytics as a Novel Treatment for Interstitial Lung Disease in Common Variable Immunodeficiency (CVID)","has_exemption":false,"start_date":"2023-04-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Avni Joshi","sponsor_slug":"avni-joshi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05765175","publication_url":"https://clinicaltrials.gov/study/NCT05765175","title":"Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia","has_exemption":false,"start_date":"2023-04-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05855135","publication_url":"https://clinicaltrials.gov/study/NCT05855135","title":"Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects With Heart Failure and Reduced Ejection Fraction","has_exemption":false,"start_date":"2023-05-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Impulse Dynamics","sponsor_slug":"impulse-dynamics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05732831","publication_url":"https://clinicaltrials.gov/study/NCT05732831","title":"A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 as a Single Agent and in Combination in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-05-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Tango Therapeutics, Inc.","sponsor_slug":"tango-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05914831","publication_url":"https://clinicaltrials.gov/study/NCT05914831","title":"Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI): A Single-Institution Prospective Phase 2 Trial","has_exemption":false,"start_date":"2023-06-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Oncology Institute of Vojvodina","sponsor_slug":"oncology-institute-of-vojvodina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05893498","publication_url":"https://clinicaltrials.gov/study/NCT05893498","title":"Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment","has_exemption":false,"start_date":"2023-06-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"CathWorks Ltd.","sponsor_slug":"cathworks-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05526001","publication_url":"https://clinicaltrials.gov/study/NCT05526001","title":"A Phase III, Randomized, Parallel, Double-blinding, 2-Arm Study to Investigate the Efficacy and Safety of Intra-articular ELIXCYTE (Adipose-Derived Stem Cells) Injection Compared With Placebo in Subjects With Knee Osteoarthritis","has_exemption":false,"start_date":"2023-07-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"UnicoCell Biomed CO. LTD","sponsor_slug":"unicocell-biomed-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05710848","publication_url":"https://clinicaltrials.gov/study/NCT05710848","title":"A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer","has_exemption":false,"start_date":"2023-07-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"SURGE Therapeutics","sponsor_slug":"surge-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05929079","publication_url":"https://clinicaltrials.gov/study/NCT05929079","title":"A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight: A Randomized Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2023-07-11","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05874414","publication_url":"https://clinicaltrials.gov/study/NCT05874414","title":"Phase 1b/2a Study of GNS561 in Combination With Trametinib in Advanced KRAS Mutated Cholangiocarcinoma","has_exemption":false,"start_date":"2023-08-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Genfit","sponsor_slug":"genfit","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05999851","publication_url":"https://clinicaltrials.gov/study/NCT05999851","title":"Multiparametric Assessment of Maternal Vascular Function as a New Diagnostic and Prognostic Tool for Hypertensive Disorders of Pregnancy and Preeclampsia - EDIPE Study","has_exemption":false,"start_date":"2023-09-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","sponsor_slug":"irccs-azienda-ospedaliero-universitaria-di-bologna","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05797805","publication_url":"https://clinicaltrials.gov/study/NCT05797805","title":"A Phase 1/2 Exploratory Study of the TBL1 Inhibitor, Tegavivint (BC2059), in Patients With Advanced Hepatocellular Carcinoma","has_exemption":false,"start_date":"2023-09-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Iterion Therapeutics","sponsor_slug":"iterion-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05867329","publication_url":"https://clinicaltrials.gov/study/NCT05867329","title":"A Sequential Multiple Assignment Randomized Trial (SMART) Feasibility Pilot Developing and Optimizing Patient-Tailored Adaptive Treatment Strategies (ATS) for Acute Severe Ulcerative Colitis (ASUC)","has_exemption":false,"start_date":"2023-09-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Berinstein, Jeffrey","sponsor_slug":"berinstein-jeffrey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087653","publication_url":"https://clinicaltrials.gov/study/NCT06087653","title":"A Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Administration of Low-dose Lenalidomide (STAR-LLD) for the Treatment of Multiple Myeloma (MM)","has_exemption":false,"start_date":"2023-10-02","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Starton Therapeutics, Inc","sponsor_slug":"starton-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06075667","publication_url":"https://clinicaltrials.gov/study/NCT06075667","title":"Efficacy, Safety, and Pharmacokinetics of Tirzepatide Once Weekly Versus Placebo in Adolescent Participants Who Have Obesity, or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind Trial (SURMOUNT-ADOLESCENTS)","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915922","publication_url":"https://clinicaltrials.gov/study/NCT06915922","title":"Therapeutic Neodymium-doped Yttrium-Aluminum-Garnet (Nd:YAG) Laser Vitreolysis for Vitreous Floaters - A Study to Quantify Visual Quality of Life, Vitreous Structure, and Vision Before and After Nd:YAG Laser Vitreolysis in Patients With Vision Degrading Myodesopsia","has_exemption":false,"start_date":"2023-10-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"VMR Consulting, Inc.","sponsor_slug":"vmr-consulting-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06489431","publication_url":"https://clinicaltrials.gov/study/NCT06489431","title":"Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement: A Prospective Non-inferiority Trial","has_exemption":false,"start_date":"2023-12-04","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06165419","publication_url":"https://clinicaltrials.gov/study/NCT06165419","title":"A Phase II Study Evaluating Definitive Radiosurgical Decompression in Patients With High-Risk Spinal Metastases","has_exemption":false,"start_date":"2023-12-14","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948475","publication_url":"https://clinicaltrials.gov/study/NCT05948475","title":"A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib VS Physician's Choice in Subjects With FGFR-altered, Chemotherapy- and FGFR Inhibitor-Cholangiocarcinoma","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"TransThera Sciences (Nanjing), Inc.","sponsor_slug":"transthera-sciences-nanjing-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058013","publication_url":"https://clinicaltrials.gov/study/NCT06058013","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2023-12-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06058039","publication_url":"https://clinicaltrials.gov/study/NCT06058039","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05558358","publication_url":"https://clinicaltrials.gov/study/NCT05558358","title":"Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05762055","publication_url":"https://clinicaltrials.gov/study/NCT05762055","title":"Prospective Comparative Analysis Evaluating Radiographic and Clinical Outcomes of Stand-Alone Anterior Cervical Discectomy and Fusion Interbody Cages With nanoLOCK Osseointegrative Technology","has_exemption":false,"start_date":"2024-02-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06266494","publication_url":"https://clinicaltrials.gov/study/NCT06266494","title":"Prevention and Treatment of Frostbite Infection With Antimicrobial Pharmacokinetic Analysis","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170450","publication_url":"https://clinicaltrials.gov/study/NCT06170450","title":"CYclic Versus Continuous Sacral Modulation for LowEr Urinary Tract Symptoms: a Prospective Randomized Controlled Trial (CYCLE Trial)","has_exemption":false,"start_date":"2024-04-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06228235","publication_url":"https://clinicaltrials.gov/study/NCT06228235","title":"Optimizing the rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings","has_exemption":false,"start_date":"2024-04-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"West Virginia University","sponsor_slug":"west-virginia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06263452","publication_url":"https://clinicaltrials.gov/study/NCT06263452","title":"Beta-Blocker Influences on Inflammatory and Neural Responses to Stress","has_exemption":false,"start_date":"2024-05-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06309966","publication_url":"https://clinicaltrials.gov/study/NCT06309966","title":"A Phase 2/3 Multicenter, Randomization, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy","has_exemption":false,"start_date":"2024-05-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055439","publication_url":"https://clinicaltrials.gov/study/NCT06055439","title":"A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 (CDH17) Chimeric Antigen Receptor (CAR) T Cell Therapy for the Treatment of Relapsed or Refractory Gastrointestinal Cancers","has_exemption":false,"start_date":"2024-05-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Chimeric Therapeutics","sponsor_slug":"chimeric-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06414954","publication_url":"https://clinicaltrials.gov/study/NCT06414954","title":"A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 Dose Levels of NMD670 Over 21 Days in Adult Patients With AChR/MuSK-Ab+ Myasthenia Gravis","has_exemption":false,"start_date":"2024-05-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"NMD Pharma A/S","sponsor_slug":"nmd-pharma-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06347133","publication_url":"https://clinicaltrials.gov/study/NCT06347133","title":"Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Hypertriglyceridemia","has_exemption":false,"start_date":"2024-05-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Pharmaceuticals","sponsor_slug":"arrowhead-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111768","publication_url":"https://clinicaltrials.gov/study/NCT06111768","title":"Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study","has_exemption":false,"start_date":"2024-05-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06284824","publication_url":"https://clinicaltrials.gov/study/NCT06284824","title":"Prospective, Randomized, Single-center Study Comparing the Stryker MAKO™ Robotic-Arm Assisted Total Knee Arthroplasty and the DePuy VELYS™ Robotic-Assisted Solution for Total Knee Arthroplasty.","has_exemption":false,"start_date":"2024-05-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Southeast Orthopedic Specialists","sponsor_slug":"southeast-orthopedic-specialists","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06170606","publication_url":"https://clinicaltrials.gov/study/NCT06170606","title":"Prospective Multi-Site Safety and Effectiveness Study of the Boston Scientific Cardiac Cryoablation System for Drug Refractory, Recurrent Symptomatic Paroxysmal Atrial Fibrillation","has_exemption":false,"start_date":"2024-06-28","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400004","publication_url":"https://clinicaltrials.gov/study/NCT06400004","title":"A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced Echocardiography","has_exemption":false,"start_date":"2024-07-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Bracco Diagnostics, Inc","sponsor_slug":"bracco-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462612","publication_url":"https://clinicaltrials.gov/study/NCT06462612","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Lumateperone in the Acute Treatment of Patients With Manic Episodes or Manic Episodes With Mixed Features Associated With Bipolar I Disorder (Bipolar Mania)","has_exemption":false,"start_date":"2024-07-17","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580873","publication_url":"https://clinicaltrials.gov/study/NCT06580873","title":"Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)","has_exemption":false,"start_date":"2024-09-30","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Saskatchewan Health Authority - Regina Area","sponsor_slug":"saskatchewan-health-authority-regina-area","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919042","publication_url":"https://clinicaltrials.gov/study/NCT06919042","title":"A Prospective Single-center Study for Evaluation of the Effectiveness of Pulsed Acoustic Cellular Expression Technology on Post-Operative Soft Tissue Fibrosis.","has_exemption":false,"start_date":"2024-10-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06519955","publication_url":"https://clinicaltrials.gov/study/NCT06519955","title":"Peri-incisional Local Infiltration to Improve Pain Control After Periacetabular Osteotomy","has_exemption":false,"start_date":"2024-10-03","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Michael C Willey","sponsor_slug":"michael-c-willey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04044534","publication_url":"https://clinicaltrials.gov/study/NCT04044534","title":"Intranasal Insulin for Treating Posttraumatic Stress Disorder","has_exemption":false,"start_date":"2024-10-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"VA Connecticut Healthcare System","sponsor_slug":"va-connecticut-healthcare-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06496035","publication_url":"https://clinicaltrials.gov/study/NCT06496035","title":"Blood Flow Restriction Training Versus Traditional Rehab in Patients With Lower Extremity Fractures: Effect on Fracture Healing, Muscle Strength and Girth, and Return to Function","has_exemption":false,"start_date":"2024-11-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Denver Health and Hospital Authority","sponsor_slug":"denver-health-and-hospital-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06492733","publication_url":"https://clinicaltrials.gov/study/NCT06492733","title":"A Pivotal, Single-arm, Multi-centre, Prospective Clinical Investigation to Assess the Efficacy and Safety of the FastWire REvascularisation of Extremities, (For LOWer Limbs) (FREEFLOW).","has_exemption":false,"start_date":"2024-11-05","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Versono Medical Ltd","sponsor_slug":"versono-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453642","publication_url":"https://clinicaltrials.gov/study/NCT06453642","title":"Evaluation of a Simple-Prep Controlled Embolic (GPX Trial)","has_exemption":false,"start_date":"2024-11-18","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Fluidx Medical Technology, Inc.","sponsor_slug":"fluidx-medical-technology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06682910","publication_url":"https://clinicaltrials.gov/study/NCT06682910","title":"An Early Feasibility Trial to Assess the Safety and Accuracy of the Microtech System in Heart Failure Patients Undergoing Left Ventricular Assist Device Implantation","has_exemption":false,"start_date":"2024-12-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Microtech Medical Technologies, Ltd","sponsor_slug":"microtech-medical-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727552","publication_url":"https://clinicaltrials.gov/study/NCT06727552","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-12-18","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07002398","publication_url":"https://clinicaltrials.gov/study/NCT07002398","title":"A Single Arm, Ph1/2, Open-label, Multicenter Trial With Dose-exploration Via Subretinal Injection to Evaluate the Safety and Preliminary Efficacy of VG801 for Treatment of ABCA4 Mutation-associated Recessive Hereditary Retinal Dystrophy (Stargardt Disease)","has_exemption":false,"start_date":"2024-12-23","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"VeonGen Therapeutics GmbH","sponsor_slug":"veongen-therapeutics-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671119","publication_url":"https://clinicaltrials.gov/study/NCT06671119","title":"REvision of VSG with Ablation of the Mucosa Procedure","has_exemption":false,"start_date":"2024-12-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Dr. Christopher McGowan","sponsor_slug":"dr-christopher-mcgowan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06777576","publication_url":"https://clinicaltrials.gov/study/NCT06777576","title":"Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Wandercraft","sponsor_slug":"wandercraft","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06750809","publication_url":"https://clinicaltrials.gov/study/NCT06750809","title":"A Prospective Post-Market Multicenter Randomized Controlled Clinical Study to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for the Management of Surgical Wounds","has_exemption":false,"start_date":"2025-02-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Avita Medical","sponsor_slug":"avita-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06518174","publication_url":"https://clinicaltrials.gov/study/NCT06518174","title":"A Novel Imaging Modality to Evaluate Radiation-Induced Uterine Injury","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06902298","publication_url":"https://clinicaltrials.gov/study/NCT06902298","title":"Personalized Ultrasonic Brain Stimulation for Depression: A Study of Target Engagement and Mood Effects","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Brian Mickey","sponsor_slug":"brian-mickey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915818","publication_url":"https://clinicaltrials.gov/study/NCT06915818","title":"GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Ileo-colic and Colo-colonic Anastomoses in Patients Undergoing Surgical Procedures","has_exemption":false,"start_date":"2025-03-29","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915337","publication_url":"https://clinicaltrials.gov/study/NCT06915337","title":"GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Gastric-Jejunal Anastomoses in Patients Undergoing Surgical Procedures","has_exemption":false,"start_date":"2025-03-29","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06814015","publication_url":"https://clinicaltrials.gov/study/NCT06814015","title":"Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Wandercraft","sponsor_slug":"wandercraft","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06939127","publication_url":"https://clinicaltrials.gov/study/NCT06939127","title":"A Prospective Phase II Study to Explore the Efficacy and Safety of Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant Treatment, Followed by Adjuvant Tislelizumab Therapy in Resectable Stage II-IIIB Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","sponsor_slug":"tianjin-medical-university-cancer-institute-and-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07172646","publication_url":"https://clinicaltrials.gov/study/NCT07172646","title":"A Phase I/II, Randomized, Double Blind, Placebo Controlled, Dose-Escalation and -Expansion Study to Evaluate the Safety, Tolerability, PK, and PD of Subcutaneously Administered SRSD216 in Patients With Elevated Lipoprotein(a)","has_exemption":false,"start_date":"2025-04-07","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Sirius Therapeutics Co., Ltd.","sponsor_slug":"sirius-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06597149","publication_url":"https://clinicaltrials.gov/study/NCT06597149","title":"Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06921759","publication_url":"https://clinicaltrials.gov/study/NCT06921759","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis","has_exemption":false,"start_date":"2025-04-21","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06910787","publication_url":"https://clinicaltrials.gov/study/NCT06910787","title":"Outpatient Virtual Reality-Directed Treatment for Pain in Inflammatory Bowel Disease","has_exemption":false,"start_date":"2025-04-29","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06924970","publication_url":"https://clinicaltrials.gov/study/NCT06924970","title":"A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter, Dose- Finding, Efficacy, and Safety Study of Tebapivat in Participants With Sickle Cell Disease","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05710315","publication_url":"https://clinicaltrials.gov/study/NCT05710315","title":"Single-center, Proof of Concept, Prospective Study Evaluating the Utility of RELiZORB™ for the Treatment of Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure","has_exemption":false,"start_date":"2025-05-07","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06628037","publication_url":"https://clinicaltrials.gov/study/NCT06628037","title":"A Phase 1 Maximum Tolerated Dose Study of SN514-066b in Adult Patients With Deep Partial Thickness Dermal Burns","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"SERDA bv","sponsor_slug":"serda-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06963476","publication_url":"https://clinicaltrials.gov/study/NCT06963476","title":"rTMS as Add on Treatment for Substance Use Disorders","has_exemption":false,"start_date":"2025-05-12","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133387","publication_url":"https://clinicaltrials.gov/study/NCT06133387","title":"PARADIGM Study: Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"EndoQuest Robotics, Inc.","sponsor_slug":"endoquest-robotics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06804551","publication_url":"https://clinicaltrials.gov/study/NCT06804551","title":"A Single-center, Prospective, Double-blind, Randomized Controlled Trial Evaluating Iovera° Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Facet-mediated Chronic Low Back Pain","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06643299","publication_url":"https://clinicaltrials.gov/study/NCT06643299","title":"PURE-LC - Probiotic Use for Recovery Enhancement From Long COVID","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06987513","publication_url":"https://clinicaltrials.gov/study/NCT06987513","title":"RECLAIM STUDY: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Altimmune, Inc.","sponsor_slug":"altimmune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926881","publication_url":"https://clinicaltrials.gov/study/NCT06926881","title":"Oscillating Lung Expansion (OLE) Therapy in the Bronchiectasis Patients (BE) Home Care Study Protocol","has_exemption":false,"start_date":"2025-05-20","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Delve Health","sponsor_slug":"delve-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999356","publication_url":"https://clinicaltrials.gov/study/NCT06999356","title":"Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring In Predominantly Hispanic/Latino Adults With Non-Insulin Treated Type 2 Diabetes And An HbA1c > 9%","has_exemption":false,"start_date":"2025-05-22","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Sutter Health","sponsor_slug":"sutter-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07137793","publication_url":"https://clinicaltrials.gov/study/NCT07137793","title":"Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients","has_exemption":false,"start_date":"2025-05-25","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06979466","publication_url":"https://clinicaltrials.gov/study/NCT06979466","title":"Facilitation Recovery For Patients With Chronic Stroke: The Q Therapeutic System, Frequency-Tuned Electromagnetic Field Treatment","has_exemption":false,"start_date":"2025-05-26","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Burke Rehabilitation Hospital","sponsor_slug":"burke-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06443047","publication_url":"https://clinicaltrials.gov/study/NCT06443047","title":"Suturing Through-the-scope System Used for Prophylactic Closure of Colonic Post-ESD Defects: A Randomized Trial vs Conventional Clips That it Highlights the Importance of Suturing in Promoting Healing and Closure of the Colonic ESD Defects","has_exemption":false,"start_date":"2025-06-01","completion_date":"2026-05-31","has_results":false,"results_due":false,"sponsor_name":"Istituto Clinico Humanitas","sponsor_slug":"istituto-clinico-humanitas","status":"ongoing","is_pact":false,"days_late":null}]}